{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:05Z","timestamp":1785761345286,"version":"3.56.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ3\/02578"],"award-info":[{"award-number":["2019\/33\/B\/NZ3\/02578"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2022\/46\/E\/NZ3\/00200"],"award-info":[{"award-number":["2022\/46\/E\/NZ3\/00200"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ3\/02578"],"award-info":[{"award-number":["2019\/33\/B\/NZ3\/02578"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2022\/46\/E\/NZ3\/00200"],"award-info":[{"award-number":["2022\/46\/E\/NZ3\/00200"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Necrotic death of pancreatic acinar cells leads to premature activation of digestive enzymes and is a central driver of inflammation in acute pancreatitis (AP). In contrast, apoptosis is a non-lytic, regulated form of cell death that prevents the release of intracellular content and is therefore considered less damaging. The induction of the intrinsic apoptotic pathway is tightly regulated by the balance between pro- and anti-apoptotic members of the BCL2 protein family. Pharmacological inhibitors of anti-apoptotic BCL2 proteins \u2013 BH3 mimetics \u2013 have thus emerged as tools to therapeutically shift cell fate from necrosis to apoptosis. Early-generation BH3 mimetics such as HA14-1 and BH3I-2\u2032 used to validate this concept were hindered by limited potency and significant off-target effects, including disruption of calcium homeostasis. More selective and potent second-generation agents \u2013 particularly Navitoclax (ABT-263) and Venetoclax (ABT-199) \u2013 have overcome these limitations, with Venetoclax now approved for clinical use in haematological malignancies. Here, we explore the therapeutic potential of BCL2 inhibitors in pancreatic diseases, with a focus on AP and a comparison to chronic pancreatitis (CP). In AP models, BCL2 inhibition \u2013 especially with Venetoclax \u2013 redirects cell death from necrosis to apoptosis, preserving intracellular ATP, attenuating aberrant Ca\n                    <jats:sup>2+<\/jats:sup>\n                    signalling, and reducing tissue damage and inflammation, without overt toxicity to healthy acinar cells in the absence of injurious stimuli. In contrast, in CP, a disease marked by fibrosis and prevailing apoptotic loss of parenchyma, BCL2 inhibition provides no benefit and may exacerbate acinar atrophy and fibrogenesis. We discuss the mechanistic basis of these divergent effects, including the role of BCL2 proteins in cell death regulation and calcium dynamics. Finally, we highlight future directions, including the rationale for clinical testing of Venetoclax in AP, and discuss cautionary considerations for its use in CP, particularly in patients with coexisting conditions such as leukaemia, who may already be receiving BH3 mimetics.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03179-8","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T16:03:08Z","timestamp":1780156988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BCL2 inhibition in acute and chronic pancreatitis \u2014 is there a therapeutic perspective?"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6730-333X","authenticated-orcid":false,"given":"Jacek J.","family":"Litewka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4899-2606","authenticated-orcid":false,"given":"Monika A.","family":"Jakubowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-6588","authenticated-orcid":false,"given":"Pawel E.","family":"Ferdek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"3179_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cdd.2017.179","volume":"25","author":"H Kalkavan","year":"2018","unstructured":"Kalkavan H, Green DR. MOMP, cell suicide as a BCL-2 family business. Cell Death Differ. 2018;25:46\u201355.","journal-title":"Cell Death Differ"},{"key":"3179_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"Vringer E, Tait SWG. Mitochondria and cell death-associated inflammation. Cell Death Differ. 2023;30:304\u201312.","journal-title":"Cell Death Differ"},{"key":"3179_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24:732\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3179_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3179_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1126\/science.1081208","volume":"300","author":"L Scorrano","year":"2003","unstructured":"Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T, et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science. 2003;300:135\u20139.","journal-title":"Science"},{"key":"3179_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.molcel.2012.12.022","volume":"49","author":"B Schellenberg","year":"2013","unstructured":"Schellenberg B, Wang P, Keeble JA, Rodriguez-Enriquez R, Walker S, Owens TW, et al. Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming. Mol Cell. 2013;49:959\u201371.","journal-title":"Mol Cell"},{"key":"3179_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2011.02.034","volume":"145","author":"F Edlich","year":"2011","unstructured":"Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, et al. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell. 2011;145:104\u201316.","journal-title":"Cell"},{"key":"3179_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","volume":"2","author":"A Letai","year":"2002","unstructured":"Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2002;2:183\u201392.","journal-title":"Cancer Cell"},{"key":"3179_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3179_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","volume":"1813","author":"D Westphal","year":"2011","unstructured":"Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. 2011;1813:521\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"3179_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"MC Wei","year":"2001","unstructured":"Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727\u201330.","journal-title":"Science"},{"key":"3179_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1074\/jbc.RA119.011635","volume":"295","author":"T Kuwana","year":"2020","unstructured":"Kuwana T, King LE, Cosentino K, Suess J, Garcia-Saez AJ, Gilmore AP, et al. Mitochondrial residence of the apoptosis inducer BAX is more important than BAX oligomerization in promoting membrane permeabilization. J Biol Chem. 2020;295:1623\u201336.","journal-title":"J Biol Chem"},{"key":"3179_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02825-7","volume":"7","author":"M Zhang","year":"2017","unstructured":"Zhang M, Zheng J, Nussinov R, Ma B. Release of cytochrome C from bax pores at the mitochondrial membrane. Sci Rep. 2017;7:2635.","journal-title":"Sci Rep"},{"key":"3179_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","volume":"44","author":"F Llambi","year":"2011","unstructured":"Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL, et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell. 2011;44:517\u201331.","journal-title":"Mol Cell"},{"key":"3179_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","volume":"9","author":"M Certo","year":"2006","unstructured":"Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell. 2006;9:351\u201365.","journal-title":"Cancer Cell"},{"key":"3179_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/cdd.2017.183","volume":"25","author":"J Montero","year":"2018","unstructured":"Montero J, Letai A. Why do BCL-2 inhibitors work and where should we use them in the clinic? Cell Death Differ. 2018;25:56\u201364.","journal-title":"Cell Death Differ"},{"key":"3179_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ddr.21405","volume":"78","author":"PE Ferdek","year":"2017","unstructured":"Ferdek PE, Jakubowska MA. On BH3 mimetics and Ca2+ signaling. Drug Dev Res. 2017;78:313\u20138.","journal-title":"Drug Dev Res"},{"key":"3179_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2011.12.021","volume":"332","author":"V Del Gaizo Moore","year":"2013","unstructured":"Del Gaizo Moore V, Letai A. BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 2013;332:202\u20135.","journal-title":"Cancer Lett"},{"key":"3179_CR19","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","volume":"97","author":"JL Wang","year":"2000","unstructured":"Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula SM, et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA. 2000;97:7124\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3179_CR20","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-03-3648","volume":"64","author":"JH Hao","year":"2004","unstructured":"Hao JH, Yu M, Liu FT, Newland AC, Jia L. Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells. Cancer Res. 2004;64:3607\u201316.","journal-title":"Cancer Res"},{"key":"3179_CR21","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.3324\/haematol.2012.080598","volume":"98","author":"H Akl","year":"2013","unstructured":"Akl H, Vandecaetsbeek I, Monaco G, Kauskot A, Luyten T, Welkenhuyzen K, et al. HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines. Haematologica. 2013;98:e49\u201351.","journal-title":"Haematologica"},{"key":"3179_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00424-010-0859-4","volume":"460","author":"J Gerasimenko","year":"2010","unstructured":"Gerasimenko J, Ferdek P, Fischer L, Gukovskaya AS, Pandol SJ. Inhibitors of Bcl-2 protein family deplete ER Ca2+ stores in pancreatic acinar cells. Pflugers Arch. 2010;460:891\u2013900.","journal-title":"Pflugers Arch"},{"key":"3179_CR23","first-page":"1498","volume":"60","author":"JL Wang","year":"2000","unstructured":"Wang JL, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce CM, et al. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res. 2000;60:1498\u2013502.","journal-title":"Cancer Res"},{"key":"3179_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/35055085","volume":"3","author":"A Degterev","year":"2001","unstructured":"Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol. 2001;3:173\u201382.","journal-title":"Nat Cell Biol"},{"key":"3179_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.41","volume":"8","author":"PE Ferdek","year":"2017","unstructured":"Ferdek PE, Jakubowska MA, Nicolaou P, Gerasimenko JV, Gerasimenko OV, Petersen OH. BH3 mimetic-elicited Ca2+ signals in pancreatic acinar cells are dependent on Bax and can be reduced by Ca2+-like peptides. Cell Death Dis. 2017;8:e2640.","journal-title":"Cell Death Dis"},{"key":"3179_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435:677\u201381.","journal-title":"Nature"},{"key":"3179_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.109","volume":"3","author":"RW Rooswinkel","year":"2012","unstructured":"Rooswinkel RW, van de Kooij B, Verheij M, Borst J. Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B. Cell Death Dis. 2012;3:e366.","journal-title":"Cell Death Dis"},{"key":"3179_CR28","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1182\/blood-2011-04-347849","volume":"118","author":"SM Schoenwaelder","year":"2011","unstructured":"Schoenwaelder SM, Jarman KE, Gardiner EE, Hua M, Qiao J, White MJ, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011;118:1663\u201374.","journal-title":"Blood"},{"key":"3179_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128:1173\u201386.","journal-title":"Cell"},{"key":"3179_CR30","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","volume":"68","author":"C Tse","year":"2008","unstructured":"Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 2008;68:3421\u20138.","journal-title":"Cancer Res"},{"key":"3179_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/cdd.2008.137","volume":"16","author":"M Vogler","year":"2009","unstructured":"Vogler M, Dinsdale D, Dyer MJ, Cohen GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ. 2009;16:360\u20137.","journal-title":"Cell Death Differ"},{"key":"3179_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/blood-2011-10-387399","volume":"119","author":"SM Schoenwaelder","year":"2012","unstructured":"Schoenwaelder SM, Jackson SP. Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood. 2012;119:1320\u20131.","journal-title":"Blood"},{"key":"3179_CR33","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.1182\/blood-2011-03-344812","volume":"117","author":"M Vogler","year":"2011","unstructured":"Vogler M, Hamali HA, Sun XM, Bampton ET, Dinsdale D, Snowden RT, et al. BCL2\/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117:7145\u201354.","journal-title":"Blood"},{"key":"3179_CR34","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","volume":"11","author":"WH Wilson","year":"2010","unstructured":"Wilson WH, O\u2019Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11:1149\u201359.","journal-title":"Lancet Oncol"},{"key":"3179_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","volume":"30","author":"AW Roberts","year":"2012","unstructured":"Roberts AW, Seymour JF, Brown JR, Wierda WG, Kipps TJ, Khaw SL, et al. Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol. 2012;30:488\u201396.","journal-title":"J Clin Oncol"},{"key":"3179_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19:202\u20138.","journal-title":"Nat Med"},{"key":"3179_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med. 2016;374:311\u201322.","journal-title":"N Engl J Med"},{"key":"3179_CR38","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.cell.2016.05.080","volume":"165","author":"DR Green","year":"2016","unstructured":"Green DR. A BH3 mimetic for killing cancer cells. Cell. 2016;165:1560.","journal-title":"Cell"},{"key":"3179_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1182\/blood.2020008502","volume":"138","author":"TE Lew","year":"2021","unstructured":"Lew TE, Tam CS, Seymour JF. How I treat chronic lymphocytic leukemia after venetoclax. Blood. 2021;138:361\u20139.","journal-title":"Blood"},{"key":"3179_CR40","doi-asserted-by":"crossref","unstructured":"Anderson MA, Walewska R, Hackett F, Kater AP, Montegaard J, O\u2019Brien S et al. Venetoclax initiation in chronic lymphocytic leukemia: international insights and innovative approaches for optimal patient care. Cancers 2024;16:980.","DOI":"10.3390\/cancers16050980"},{"key":"3179_CR41","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbamcr.2016.11.024","volume":"1864","author":"T Vervloessem","year":"2017","unstructured":"Vervloessem T, Ivanova H, Luyten T, Parys JB, Bultynck G. The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling. Biochim Biophys Acta. 2017;1864:968\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"3179_CR42","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1111\/bph.14505","volume":"176","author":"MA Jakubowska","year":"2019","unstructured":"Jakubowska MA, Kerkhofs M, Martines C, Efremov DG, Gerasimenko JV, Gerasimenko OV, et al. ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca(2+) -signalling dysregulation or toxicity in pancreatic acinar cells. Br J Pharmacol. 2019;176:4402\u201315.","journal-title":"Br J Pharmacol"},{"key":"3179_CR43","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1152\/physrev.00003.2021","volume":"101","author":"OH Petersen","year":"2021","unstructured":"Petersen OH, Gerasimenko JV, Gerasimenko OV, Gryshchenko O, Peng S. The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas. Physiol Rev. 2021;101:1691\u2013744.","journal-title":"Physiol Rev"},{"key":"3179_CR44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ceca.2009.02.005","volume":"45","author":"OH Petersen","year":"2009","unstructured":"Petersen OH, Tepikin AV, Gerasimenko JV, Gerasimenko OV, Sutton R, Criddle DN. Fatty acids, alcohol and fatty acid ethyl esters: toxic Ca2+ signal generation and pancreatitis. Cell Calcium. 2009;45:634\u201342.","journal-title":"Cell Calcium"},{"key":"3179_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1113\/jphysiol.2013.261784","volume":"592","author":"JV Gerasimenko","year":"2014","unstructured":"Gerasimenko JV, Gerasimenko OV, Petersen OH. The role of Ca2+ in the pathophysiology of pancreatitis. J Physiol. 2014;592:269\u201380.","journal-title":"J Physiol"},{"key":"3179_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1159\/000082182","volume":"4","author":"AS Gukovskaya","year":"2004","unstructured":"Gukovskaya AS, Pandol SJ. Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology. 2004;4:567\u201386.","journal-title":"Pancreatology"},{"key":"3179_CR47","doi-asserted-by":"publisher","first-page":"G189","DOI":"10.1152\/ajpgi.00304.2003","volume":"286","author":"M Bhatia","year":"2004","unstructured":"Bhatia M. Apoptosis versus necrosis in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2004;286:G189\u2013196.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3179_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1582-4934.2004.tb00330.x","volume":"8","author":"M Bhatia","year":"2004","unstructured":"Bhatia M. Apoptosis of pancreatic acinar cells in acute pancreatitis: is it good or bad? J Cell Mol Med. 2004;8:402\u20139.","journal-title":"J Cell Mol Med"},{"key":"3179_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07881-w","volume":"16","author":"JJ Litewka","year":"2025","unstructured":"Litewka JJ, Szopa MD, Fryt K, Jakubowska MA, Jankowska U, Skupien-Rabian B, et al. Repurposing BCL2 inhibitors: venetoclax protects against acinar cell necrosis in acute pancreatitis by promoting apoptosis. Cell Death Dis. 2025;16:566.","journal-title":"Cell Death Dis"},{"key":"3179_CR50","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.cdd.4402150","volume":"14","author":"DN Criddle","year":"2007","unstructured":"Criddle DN, Gerasimenko JV, Baumgartner HK, Jaffar M, Voronina S, Sutton R, et al. Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ. 2007;14:1285\u201394.","journal-title":"Cell Death Differ"},{"key":"3179_CR51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1053\/j.gastro.2005.12.031","volume":"130","author":"DN Criddle","year":"2006","unstructured":"Criddle DN, Murphy J, Fistetto G, Barrow S, Tepikin AV, Neoptolemos JP, et al. Fatty acid ethyl esters cause pancreatic calcium toxicity via inositol trisphosphate receptors and loss of ATP synthesis. Gastroenterology. 2006;130:781\u201393.","journal-title":"Gastroenterology"},{"key":"3179_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1083\/jcb.200309146","volume":"166","author":"R Chen","year":"2004","unstructured":"Chen R, Valencia I, Zhong F, McColl KS, Roderick HL, Bootman MD, et al. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol. 2004;166:193\u2013203.","journal-title":"J Cell Biol"},{"key":"3179_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1073\/pnas.0408352102","volume":"102","author":"SA Oakes","year":"2005","unstructured":"Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T, et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci USA. 2005;102:105\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3179_CR54","first-page":"2782","volume":"127","author":"T Vervliet","year":"2014","unstructured":"Vervliet T, Decrock E, Molgo J, Sorrentino V, Missiaen L, Leybaert L, et al. Bcl-2 binds to and inhibits ryanodine receptors. J Cell Sci. 2014;127:2782\u201392.","journal-title":"J Cell Sci"},{"key":"3179_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep09641","volume":"5","author":"T Vervliet","year":"2015","unstructured":"Vervliet T, Lemmens I, Vandermarliere E, Decrock E, Ivanova H, Monaco G, et al. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain. Sci Rep. 2015;5:9641.","journal-title":"Sci Rep"},{"key":"3179_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnves.2025.100050","volume":"2","author":"D Liao","year":"2026","unstructured":"Liao D, Li Z, Sun Z, Jia Y, He X, Yang X, et al. Calcium entry channels and their role in the pathogenesis of acute pancreatitis. Cell Invest. 2026;2:100050.","journal-title":"Cell Invest"},{"key":"3179_CR57","doi-asserted-by":"publisher","first-page":"113840","DOI":"10.3748\/wjg.v31.i48.113840","volume":"31","author":"CC Xia","year":"2025","unstructured":"Xia CC, Xu Y, Wang ZH, Xu GQ. Mitochondrial dysfunction as a bridge to pathology in acute pancreatitis: From molecular insights to novel therapeutic strategies. World J Gastroenterol. 2025;31:113840.","journal-title":"World J Gastroenterol"},{"key":"3179_CR58","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cub.2012.05.002","volume":"22","author":"PE Ferdek","year":"2012","unstructured":"Ferdek PE, Gerasimenko JV, Peng S, Tepikin AV, Petersen OH, Gerasimenko OV. A novel role for Bcl-2 in regulation of cellular calcium extrusion. Curr Biol. 2012;22:1241\u20136.","journal-title":"Curr Biol"},{"key":"3179_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1394137","volume":"11","author":"Y Sun","year":"2024","unstructured":"Sun Y, Xu H, Gao W, Deng J, Song X, Li J, et al. S100a8\/A9 proteins: critical regulators of inflammation in cardiovascular diseases. Front Cardiovasc Med. 2024;11:1394137.","journal-title":"Front Cardiovasc Med"},{"key":"3179_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.614591","volume":"11","author":"X Yang","year":"2020","unstructured":"Yang X, Yao L, Fu X, Mukherjee R, Xia Q, Jakubowska MA, et al. Experimental acute pancreatitis models: history, current status, and role in translational research. Front Physiol. 2020;11:614591.","journal-title":"Front Physiol"},{"key":"3179_CR61","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.yexcr.2009.01.009","volume":"315","author":"KF Sung","year":"2009","unstructured":"Sung KF, Odinokova IV, Mareninova OA, Rakonczay Z Jr, Hegyi P, et al. Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis. Exp Cell Res. 2009;315:1975\u201389.","journal-title":"Exp Cell Res"},{"key":"3179_CR62","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/35037722","volume":"407","author":"J Savill","year":"2000","unstructured":"Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784\u20138.","journal-title":"Nature"},{"key":"3179_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(20)31318-0","volume":"396","author":"G Beyer","year":"2020","unstructured":"Beyer G, Habtezion A, Werner J, Lerch MM, Mayerle J. Chronic pancreatitis. Lancet. 2020;396:499\u2013512.","journal-title":"Lancet"},{"key":"3179_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.60","volume":"3","author":"J Kleeff","year":"2017","unstructured":"Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3:17060.","journal-title":"Nat Rev Dis Primers"},{"key":"3179_CR65","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1113\/JP281135","volume":"600","author":"PE Ferdek","year":"2022","unstructured":"Ferdek PE, Krzysztofik D, Stopa KB, Kusiak AA, Paw M, Wnuk D, et al. When healing turns into killing - the pathophysiology of pancreatic and hepatic fibrosis. J Physiol. 2022;600:2579\u2013612.","journal-title":"J Physiol"},{"key":"3179_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02354-1","volume":"23","author":"JJ Litewka","year":"2025","unstructured":"Litewka JJ, Jakubowska MA, Targosz-Korecka M, Wiercigroch E, Dybas J, Cisak N, et al. Biophysical and biochemical signatures of pancreatic stellate cell activation: insights into mechano-metabolic signalling from atomic force microscopy and Raman spectroscopy. Cell Commun Signal. 2025;23:363.","journal-title":"Cell Commun Signal"},{"key":"3179_CR67","doi-asserted-by":"crossref","unstructured":"Almanzar VMD, Shah K, LaComb JF, Mojumdar A, Patel HR, Cheung J, et al. 5-FU-miR-15a inhibits activation of pancreatic stellate cells by reducing YAP1 and BCL-2 levels in vitro. Int J Mol Sci. 2023;24:3954.","DOI":"10.3390\/ijms24043954"},{"key":"3179_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pan.2012.02.008","volume":"12","author":"J Shen","year":"2012","unstructured":"Shen J, Wan R, Hu G, Yang L, Xiong J, Wang F, et al. miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro. Pancreatology. 2012;12:91\u201399.","journal-title":"Pancreatology"},{"key":"3179_CR69","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00535-008-2179-4","volume":"43","author":"L Singh","year":"2008","unstructured":"Singh L, Bakshi DK, Majumdar S, Arora SK, Vasishta RK, Wig JD. Mitochondrial dysfunction and apoptosis of acinar cells in chronic pancreatitis. J Gastroenterol. 2008;43:473\u201383.","journal-title":"J Gastroenterol"},{"key":"3179_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.gastro.2009.04.003","volume":"137","author":"F Fortunato","year":"2009","unstructured":"Fortunato F, Burgers H, Bergmann F, Rieger P, Buchler MW, Kroemer G, et al. Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology. 2009;137:350\u201360. 360 e351\u2013355.","journal-title":"Gastroenterology"},{"key":"3179_CR71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrgastro.2017.12","volume":"14","author":"P Storz","year":"2017","unstructured":"Storz P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2017;14:296\u2013304.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3179_CR72","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molmed.2020.04.003","volume":"26","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, White RA, Wang TC. Adult pancreatic acinar progenitor-like populations in regeneration and cancer. Trends Mol Med. 2020;26:758\u201367.","journal-title":"Trends Mol Med"},{"key":"3179_CR73","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gut.44.4.534","volume":"44","author":"MV Apte","year":"1999","unstructured":"Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534\u201341.","journal-title":"Gut"},{"key":"3179_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1172\/JCI30082","volume":"117","author":"MB Omary","year":"2007","unstructured":"Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest. 2007;117:50\u201359.","journal-title":"J Clin Invest"},{"key":"3179_CR75","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gut.50.4.535","volume":"50","author":"P Mews","year":"2002","unstructured":"Mews P, Phillips P, Fahmy R, Korsten M, Pirola R, Wilson J, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002;50:535\u201341.","journal-title":"Gut"},{"key":"3179_CR76","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00424-017-1968-0","volume":"469","author":"PE Ferdek","year":"2017","unstructured":"Ferdek PE, Jakubowska MA. Biology of pancreatic stellate cells-more than just pancreatic cancer. Pflugers Arch. 2017;469:1039\u201350.","journal-title":"Pflugers Arch"},{"key":"3179_CR77","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1172\/JCI119714","volume":"100","author":"AS Gukovskaya","year":"1997","unstructured":"Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest. 1997;100:1853\u201362.","journal-title":"J Clin Invest"},{"key":"3179_CR78","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1053\/j.gastro.2005.03.025","volume":"128","author":"K Shimizu","year":"2005","unstructured":"Shimizu K, Kobayashi M, Tahara J, Shiratori K. Cytokines and peroxisome proliferator-activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology. 2005;128:2105\u201318.","journal-title":"Gastroenterology"},{"key":"3179_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2147\/JIR.S299298","volume":"14","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang H, Jing Q, Yang Y, Xue D, Hao C, et al. Regulation of pancreatic fibrosis by acinar cell-derived exosomal miR-130a-3p via targeting of stellate cell PPAR-gamma. J Inflamm Res. 2021;14:461\u201377.","journal-title":"J Inflamm Res"},{"key":"3179_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"3179_CR81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005;115:56\u201365.","journal-title":"J Clin Invest"},{"key":"3179_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1113\/jphysiol.2002.017525","volume":"540","author":"S Voronina","year":"2002","unstructured":"Voronina S, Longbottom R, Sutton R, Petersen OH, Tepikin A. Bile acids induce calcium signals in mouse pancreatic acinar cells: implications for bile-induced pancreatic pathology. J Physiol. 2002;540:49\u201355.","journal-title":"J Physiol"},{"key":"3179_CR83","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 2010;11:621\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3179_CR84","doi-asserted-by":"publisher","first-page":"34433","DOI":"10.1074\/jbc.274.48.34433","volume":"274","author":"J Hirota","year":"1999","unstructured":"Hirota J, Furuichi T, Mikoshiba K. Inositol 1,4,5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J Biol Chem. 1999;274:34433\u20137.","journal-title":"J Biol Chem"},{"key":"3179_CR85","doi-asserted-by":"publisher","first-page":"43227","DOI":"10.1074\/jbc.M403872200","volume":"279","author":"Z Assefa","year":"2004","unstructured":"Assefa Z, Bultynck G, Szlufcik K, Nadif Kasri N, Vermassen E, Goris J, et al. Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis. J Biol Chem. 2004;279:43227\u201336.","journal-title":"J Biol Chem"},{"key":"3179_CR86","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1089\/ars.2011.4115","volume":"15","author":"RK Tandon","year":"2011","unstructured":"Tandon RK, Garg PK. Oxidative stress in chronic pancreatitis: pathophysiological relevance and management. Antioxid Redox Signal. 2011;15:2757\u201366.","journal-title":"Antioxid Redox Signal"},{"key":"3179_CR87","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.3748\/wjg.v12.i35.5705","volume":"12","author":"M Verlaan","year":"2006","unstructured":"Verlaan M, Roelofs HM, Van-Schaik A, Wanten GJ, Jansen JB, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol. 2006;12:5705\u201310.","journal-title":"World J Gastroenterol"},{"key":"3179_CR88","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcancer.2008.12.002","volume":"19","author":"N Susnow","year":"2009","unstructured":"Susnow N, Zeng L, Margineantu D, Hockenbery DM. Bcl-2 family proteins as regulators of oxidative stress. Semin Cancer Biol. 2009;19:42\u201349.","journal-title":"Semin Cancer Biol"},{"key":"3179_CR89","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.1073\/pnas.1005256107","volume":"107","author":"EM Carrington","year":"2010","unstructured":"Carrington EM, Vikstrom IB, Light A, Sutherland RM, Londrigan SL, Mason KD, et al. BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA. 2010;107:10967\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3179_CR90","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/bjs.10538","volume":"104","author":"T Liu","year":"2017","unstructured":"Liu T, Huang W, Szatmary P, Abrams ST, Alhamdi Y, Lin Z, et al. Accuracy of circulating histones in predicting persistent organ failure and mortality in patients with acute pancreatitis. Br J Surg. 2017;104:1215\u201325.","journal-title":"Br J Surg"},{"key":"3179_CR91","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.4049\/jimmunol.171.6.3136","volume":"171","author":"A Iwata","year":"2003","unstructured":"Iwata A, Stevenson VM, Minard A, Tasch M, Tupper J, Lagasse E, et al. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol. 2003;171:3136\u201341.","journal-title":"J Immunol"},{"key":"3179_CR92","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.4049\/jimmunol.162.7.4148","volume":"162","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol. 1999;162:4148\u201356.","journal-title":"J Immunol"},{"key":"3179_CR93","doi-asserted-by":"crossref","unstructured":"Szlasa W, Kisielewska M, Sobczynska-Konefal A, Jaskula E, Mordak-Domagala M, Kwiatkowski J, et al. Venetoclax-based regimens in cll: immunoglobulin G levels, absolute neutrophil counts, and infectious complications. Biomedicines 2025;13:1609.","DOI":"10.3390\/biomedicines13071609"},{"key":"3179_CR94","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","volume":"138","author":"JB Lee","year":"2021","unstructured":"Lee JB, Khan DH, Hurren R, Xu M, Na Y, Kang H, et al. Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood. 2021;138:234\u201345.","journal-title":"Blood"},{"key":"3179_CR95","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1084\/jem.20070618","volume":"204","author":"S Wojciechowski","year":"2007","unstructured":"Wojciechowski S, Tripathi P, Bourdeau T, Acero L, Grimes HL, Katz JD, et al. Bim\/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med. 2007;204:1665\u201375.","journal-title":"J Exp Med"},{"key":"3179_CR96","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.4049\/jimmunol.1100102","volume":"186","author":"S Kurtulus","year":"2011","unstructured":"Kurtulus S, Tripathi P, Moreno-Fernandez ME, Sholl A, Katz JD, Grimes HL, et al. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J Immunol. 2011;186:5729\u201337.","journal-title":"J Immunol"},{"key":"3179_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04285-4","volume":"12","author":"LM Ludwig","year":"2021","unstructured":"Ludwig LM, Hawley KM, Banks DB, Thomas-Toth AT, Blazar BR, McNerney ME, et al. Venetoclax imparts distinct cell death sensitivity and adaptivity patterns in T cells. Cell Death Dis. 2021;12:1005.","journal-title":"Cell Death Dis"},{"key":"3179_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57000-x","volume":"10","author":"L Rohner","year":"2020","unstructured":"Rohner L, Reinhart R, Iype J, Bachmann S, Kaufmann T, Fux M. Impact of BH3-mimetics on human and mouse blood leukocytes: a comparative study. Sci Rep. 2020;10:222.","journal-title":"Sci Rep"},{"key":"3179_CR99","doi-asserted-by":"crossref","unstructured":"Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest. 1985;75:1144\u201352.","DOI":"10.1172\/JCI111809"},{"key":"3179_CR100","doi-asserted-by":"crossref","unstructured":"Salih M, Petersen OH. Activation of pancreatic acinar cells by very low concentrations of cholecystokinin: mechanism and implications for physiology and pathology. Pancreatology. 2026;343-54.","DOI":"10.1016\/j.pan.2026.03.006"},{"key":"3179_CR101","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2013-01-475855","volume":"121","author":"CJ Vandenberg","year":"2013","unstructured":"Vandenberg CJ, Cory S. ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. Blood. 2013;121:2285\u20138.","journal-title":"Blood"},{"key":"3179_CR102","doi-asserted-by":"crossref","unstructured":"Tenner S, Baillie J, DeWitt J, Vege SS & American College of, G. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2016;108:1400\u20131411.","DOI":"10.1038\/ajg.2013.218"},{"key":"3179_CR103","doi-asserted-by":"publisher","first-page":"13186","DOI":"10.1073\/pnas.1300910110","volume":"110","author":"JV Gerasimenko","year":"2013","unstructured":"Gerasimenko JV, Gryshchenko O, Ferdek PE, Stapleton E, Hebert TO, Bychkova S, et al. Ca2+ release-activated Ca2+ channel blockade as a potential tool in antipancreatitis therapy. Proc Natl Acad Sci USA. 2013;110:13186\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3179_CR104","doi-asserted-by":"crossref","unstructured":"Waldron RT, Chen Y, Pham H, Go A, Su HY, Hu C, et al. The Orai Ca(2+) channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis. J Physiol. 2019;597:3085-105.","DOI":"10.1113\/JP277856"},{"key":"3179_CR105","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1113\/JP279047","volume":"598","author":"J Fanczal","year":"2020","unstructured":"Fanczal J, Pallagi P, Gorog M, Diszhazi G, Almassy J, Madacsy T, et al. TRPM2-mediated extracellular Ca(2+) entry promotes acinar cell necrosis in biliary acute pancreatitis. J Physiol. 2020;598:1253\u201370.","journal-title":"J Physiol"},{"key":"3179_CR106","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2015.04.015","volume":"149","author":"L Wen","year":"2015","unstructured":"Wen L, Voronina S, Javed MA, Szatmary P, Latawiec D, Chvanov M, et al. Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models. Gastroenterology. 2015;149:481\u201392.","journal-title":"Gastroenterology"},{"key":"3179_CR107","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102\u201311.","journal-title":"Gut"},{"key":"3179_CR108","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.12453","volume":"273","author":"MC Greenlee-Wacker","year":"2016","unstructured":"Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev. 2016;273:357\u201370.","journal-title":"Immunol Rev"},{"key":"3179_CR109","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.smim.2015.03.014","volume":"27","author":"SE Headland","year":"2015","unstructured":"Headland SE, Norling LV. The resolution of inflammation: principles and challenges. Semin Immunol. 2015;27:149\u201360.","journal-title":"Semin Immunol"},{"key":"3179_CR110","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41420-024-01979-4","volume":"10","author":"C Li","year":"2024","unstructured":"Li C, Yu Y, Zhu S, Hu Y, Ling X, Xu L, et al. The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives. Cell Death Discov. 2024;10:216.","journal-title":"Cell Death Discov"},{"key":"3179_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06994-2","volume":"23","author":"H Liu","year":"2025","unstructured":"Liu H, Dong J, Xu C, Ni Y, Ye Z, Sun Z, et al. Acute lung injury: pathogenesis and treatment. J Transl Med. 2025;23:926.","journal-title":"J Transl Med"},{"key":"3179_CR112","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.exphem.2006.07.008","volume":"34","author":"C Campas","year":"2006","unstructured":"Campas C, Cosialls AM, Barragan M, Iglesias-Serret D, Santidrian AF, Coll-Mulet L, et al. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp Hematol. 2006;34:1663\u20139.","journal-title":"Exp Hematol"},{"key":"3179_CR113","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/cdd.2009.48","volume":"16","author":"M Vogler","year":"2009","unstructured":"Vogler M, Weber K, Dinsdale D, Schmitz I, Schulze-Osthoff K, Dyer MJ, et al. Different forms of cell death induced by putative BCL2 inhibitors. Cell Death Differ. 2009;16:1030\u20139.","journal-title":"Cell Death Differ"},{"key":"3179_CR114","doi-asserted-by":"publisher","first-page":"G63","DOI":"10.1152\/ajpgi.00257.2009","volume":"298","author":"I Ohno","year":"2010","unstructured":"Ohno I, Eibl G, Odinokova I, Edderkaoui M, Damoiseaux RD, Yazbec M, et al. Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol. 2010;298:G63\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3179_CR115","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/cdd.2008.25","volume":"15","author":"M Vogler","year":"2008","unstructured":"Vogler M, Dinsdale D, Sun XM, Young KW, Butterworth M, Nicotera P, et al. A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. Cell Death Differ. 2008;15:820\u201330.","journal-title":"Cell Death Differ"},{"key":"3179_CR116","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","volume":"10","author":"M Konopleva","year":"2006","unstructured":"Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006;10:375\u201388.","journal-title":"Cancer Cell"},{"key":"3179_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0303-8","volume":"16","author":"M Broecker-Preuss","year":"2016","unstructured":"Broecker-Preuss M, Becher-Boveleth N, Muller S, Mann K. The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells. Cancer Cell Int. 2016;16:27.","journal-title":"Cancer Cell Int"},{"key":"3179_CR118","first-page":"307","volume":"13","author":"FR Di Cristofano","year":"2023","unstructured":"Di Cristofano FR, Fong MW, Huntington KE, Carneiro BA, Zhou L, El-Deiry WS. Synergistic activity of ABT-263 and ONC201\/TIC10 against solid tumor cell lines is associated with suppression of anti-apoptotic Mcl-1, BAG3, pAkt, and upregulation of pro-apoptotic Noxa and Bax cleavage during apoptosis. Am J Cancer Res. 2023;13:307\u201325.","journal-title":"Am J Cancer Res"},{"key":"3179_CR119","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41420-020-00348-1","volume":"6","author":"S Arulananda","year":"2020","unstructured":"Arulananda S, O\u2019Brien M, Evangelista M, Harris TJ, Steinohrt NS, Jenkins LJ, et al. BCL-XL is an actionable target for treatment of malignant pleural mesothelioma. Cell Death Discov. 2020;6:114.","journal-title":"Cell Death Discov"},{"key":"3179_CR120","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1158\/1078-0432.CCR-10-0777","volume":"16","author":"M Vogler","year":"2010","unstructured":"Vogler M, Furdas SD, Jung M, Kuwana T, Dyer MJ, Cohen GM. Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in blood. Clin Cancer Res. 2010;16:4217\u201325.","journal-title":"Clin Cancer Res"},{"key":"3179_CR121","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","volume":"29","author":"L Gandhi","year":"2011","unstructured":"Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, Khaira D, et al. Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors. J Clin Oncol. 2011;29:909\u201316.","journal-title":"J Clin Oncol"},{"key":"3179_CR122","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","volume":"4","author":"R Pan","year":"2014","unstructured":"Pan R, Hogdal LJ, Benito JM, Bucci D, Han L, Borthakur G, et al. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 2014;4:362\u201375.","journal-title":"Cancer Discov"},{"key":"3179_CR123","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1713976","volume":"378","author":"JF Seymour","year":"2018","unstructured":"Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D\u2019Rozario J, Assouline S, et al. Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2018;378:1107\u201320.","journal-title":"N Engl J Med"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03179-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:02:45Z","timestamp":1785758565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03179-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3179"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03179-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"322"}}